[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://in.linkedin.com/company/camel-ids” connections=”true” suffix=””]

Camel-IDS is based on recombinant, small antigen-binding fragments derived from Camelidae heavy-chain-only antibodies (Camelids), coupled with a therapeutic radioisotope. Camelids are used to transport the radioisotope to selected cancer receptors on the cancer cell surface and will selectively kill cancer cells by irradiation.